Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin-preconditioned ASCs for Facial Contour Deformities
NCT05610878Phase 1Recruiting
- Sponsor
- University of the Punjab
- Start
- Nov 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of curcumin-preconditioned autologous adipose-derived stem cells in craniofacial anomalies (CFA), progressive hemifacial atrophy (PRS), Craniofacial microsomia (CFM) and 2 more (3 arms), sponsored by University of the Punjab. Primary endpoint: Volumetric change in facial tissue by ultrasonography at 9 months. Started Nov 2020; status: recruiting.
02
Drugs
curcumin-preconditioned autologous adipose-derived stem cells
03
Conditions
craniofacial anomalies (CFA)progressive hemifacial atrophy (PRS)Craniofacial microsomia (CFM)burn scarscar
Beyond the preview
Go deeper on NCT05610878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610878.